143 related articles for article (PubMed ID: 27230848)
21. Rescue of a cherubism bone marrow stromal culture phenotype by reducing TGFβ signaling.
Liu Y; Sharma T; Chen IP; Reichenberger E; Ueki Y; Arif Y; Parisi D; Maye P
Bone; 2018 Jun; 111():28-35. PubMed ID: 29530719
[TBL] [Abstract][Full Text] [Related]
22. Microbe-Dependent Exacerbated Alveolar Bone Destruction in Heterozygous Cherubism Mice.
Kittaka M; Yoshimoto T; Schlosser C; Kajiya M; Kurihara H; Reichenberger EJ; Ueki Y
JBMR Plus; 2020 Jun; 4(6):e10352. PubMed ID: 32537546
[TBL] [Abstract][Full Text] [Related]
23. Mutations of the SH3BP2 gene in 2 families of cherubism.
Tuna EB; Shimizu T; Seymen F; Yildirim M; Gencay K; Maeda T
Pediatr Dent; 2012; 34(3):198-202. PubMed ID: 22795151
[TBL] [Abstract][Full Text] [Related]
24. Novel nucleotide mutation leading to a recurrent amino acid alteration in SH3BP2 in a patient with cherubism.
Sangu N; Shimosato T; Inoda H; Shimada S; Shimojima K; Ando T; Yamamoto T
Congenit Anom (Kyoto); 2013 Dec; 53(4):166-9. PubMed ID: 24712477
[TBL] [Abstract][Full Text] [Related]
25. Enhanced TLR-MYD88 signaling stimulates autoinflammation in SH3BP2 cherubism mice and defines the etiology of cherubism.
Yoshitaka T; Mukai T; Kittaka M; Alford LM; Masrani S; Ishida S; Yamaguchi K; Yamada M; Mizuno N; Olsen BR; Reichenberger EJ; Ueki Y
Cell Rep; 2014 Sep; 8(6):1752-1766. PubMed ID: 25220465
[TBL] [Abstract][Full Text] [Related]
26. Investigation of the SH3BP2 gene mutation in cherubism.
Lee JY; Jung YS; Kim SA; Lee SH; Ahn SG; Yoon JH
Acta Med Okayama; 2008 Jun; 62(3):209-12. PubMed ID: 18596838
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of B-cell receptor signaling by a point mutation of adaptor protein 3BP2 identified in human inherited disease cherubism.
Ogi K; Nakashima K; Chihara K; Takeuchi K; Horiguchi T; Fujieda S; Sada K
Genes Cells; 2011 Sep; 16(9):951-60. PubMed ID: 21794028
[TBL] [Abstract][Full Text] [Related]
28. A novel mutation of the SH3BP2 gene in an aggressive case of cherubism.
Carvalho VM; Perdigão PF; Pimenta FJ; de Souza PE; Gomez RS; De Marco L
Oral Oncol; 2008 Feb; 44(2):153-5. PubMed ID: 17368082
[TBL] [Abstract][Full Text] [Related]
29. Investigating global gene expression changes in a murine model of cherubism.
Sharma T; Cotney J; Singh V; Sanjay A; Reichenberger EJ; Ueki Y; Maye P
Bone; 2020 Jun; 135():115315. PubMed ID: 32165349
[TBL] [Abstract][Full Text] [Related]
30. Cherubism as a systemic skeletal disease: evidence from an aggressive case.
Morice A; Joly A; Ricquebourg M; Maruani G; Durand E; Galmiche L; Amiel J; Vial Y; Cavé H; Belhous K; Piketty M; Cohen-Solal M; Berdal A; Collet C; Picard A; Coudert AE; Kadlub N
BMC Musculoskelet Disord; 2020 Aug; 21(1):564. PubMed ID: 32825821
[TBL] [Abstract][Full Text] [Related]
31. Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.
Lo B; Faiyaz-Ul-Haque M; Kennedy S; Aviv R; Tsui LC; Teebi AS
Am J Med Genet A; 2003 Aug; 121A(1):37-40. PubMed ID: 12900899
[TBL] [Abstract][Full Text] [Related]
32. Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.
Ueki Y; Tiziani V; Santanna C; Fukai N; Maulik C; Garfinkle J; Ninomiya C; doAmaral C; Peters H; Habal M; Rhee-Morris L; Doss JB; Kreiborg S; Olsen BR; Reichenberger E
Nat Genet; 2001 Jun; 28(2):125-6. PubMed ID: 11381256
[TBL] [Abstract][Full Text] [Related]
33. Mutations in SH3BP2, the cherubism gene, were not detected in central or peripheral giant cell tumours of the jaw.
Idowu BD; Thomas G; Frow R; Diss TC; Flanagan AM
Br J Oral Maxillofac Surg; 2008 Apr; 46(3):229-230. PubMed ID: 17544554
[TBL] [Abstract][Full Text] [Related]
34. SH3BP2-related fibro-osseous disorders of the maxilla and mandible: A systematic review.
Kueper J; Tsimbal C; Olsen BR; Kaban L; Liao EC
Int J Oral Maxillofac Surg; 2022 Jan; 51(1):54-61. PubMed ID: 33941395
[TBL] [Abstract][Full Text] [Related]
35. A novel c.1255G>T (p.D419Y) mutation in SH3BP2 gene causes cherubism in a Turkish family.
Dinckan N; Guven Y; Kayserili H; Aktoren O; Uyguner OZ
Oral Surg Oral Med Oral Pathol Oral Radiol; 2012 Nov; 114(5):e42-6. PubMed ID: 23083484
[TBL] [Abstract][Full Text] [Related]
36. NFATc1 and TNFalpha expression in giant cell lesions of the jaws.
Amaral FR; Brito JA; Perdigão PF; Carvalho VM; de Souza PE; Gomez MV; De Marco L; Gomez RS
J Oral Pathol Med; 2010 Mar; 39(3):269-74. PubMed ID: 20002873
[TBL] [Abstract][Full Text] [Related]
37. Loss-of-function
Kittaka M; Mizuno N; Morino H; Yoshimoto T; Zhu T; Liu S; Wang Z; Mayahara K; Iio K; Kondo K; Kondo T; Hayashi T; Coghlan S; Teno Y; Doan AAP; Levitan M; Choi RB; Matsuda S; Ouhara K; Wan J; Cassidy AM; Pelletier S; Nampoothiri S; Urtizberea AJ; Robling AG; Ono M; Kawakami H; Reichenberger EJ; Ueki Y
JBMR Plus; 2024 Jun; 8(6):ziae050. PubMed ID: 38699440
[TBL] [Abstract][Full Text] [Related]
38. [Mutation detection in SH3BP2 gene in a cherubism family].
Li CY; Yu SF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jun; 41(6):368-71. PubMed ID: 16836910
[TBL] [Abstract][Full Text] [Related]
39. Cherubism: best clinical practice.
Papadaki ME; Lietman SA; Levine MA; Olsen BR; Kaban LB; Reichenberger EJ
Orphanet J Rare Dis; 2012 May; 7 Suppl 1(Suppl 1):S6. PubMed ID: 22640403
[TBL] [Abstract][Full Text] [Related]
40. SH3BP2 mutations potentiate osteoclastogenesis via PLCγ.
Lietman SA; Yin L; Levine MA
J Orthop Res; 2010 Nov; 28(11):1425-30. PubMed ID: 20872577
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
